Search research articles
Contact Us
Filters
Showing results (11-20 of 128) with videos related to
Page
of 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 4, 2020
Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin Inhibitors
Melhem M Solh, Jimena Baron, Xu Zhang, et al.
Bone Marrow Transplantation
|
April 7, 2019
Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes
Melhem M Solh, Elizabeth Dickhaus, Scott R Solomon, et al.
Blood Advances
|
October 6, 2020
The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation
Melhem M Solh, Dawn Speckhart, Scott R Solomon, et al.
Transplantation and Cellular Therapy
|
March 29, 2024
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Melhem Solh, Asad Bashey, Xu Zhang, et al.
Bone Marrow Transplantation
|
September 19, 2019
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program
Scott R Solomon, Melhem Solh, Katelin C Jackson, et al.
Bone Marrow Transplantation
|
January 17, 2018
Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients
Melhem M Solh, Asad Bashey, Scott R Solomon, et al.
Blood Advances
|
March 24, 2023
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors
Asad Bashey, Xu Zhang, Lawrence E Morris, et al.
Blood Advances
|
September 24, 2025
Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation
Bhavna Bhasin-Chhabra, Tao Wang, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 3, 2017
Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint
Melhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2017
Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant
Scott R Solomon, Connie Sizemore, Xu Zhang, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 128) with videos related to
Sort By:
Page
of 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 4, 2020
Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin Inhibitors
Melhem M Solh, Jimena Baron, Xu Zhang, et al.
Bone Marrow Transplantation
|
April 7, 2019
Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes
Melhem M Solh, Elizabeth Dickhaus, Scott R Solomon, et al.
Blood Advances
|
October 6, 2020
The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation
Melhem M Solh, Dawn Speckhart, Scott R Solomon, et al.
Transplantation and Cellular Therapy
|
March 29, 2024
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Melhem Solh, Asad Bashey, Xu Zhang, et al.
Bone Marrow Transplantation
|
September 19, 2019
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program
Scott R Solomon, Melhem Solh, Katelin C Jackson, et al.
Bone Marrow Transplantation
|
January 17, 2018
Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients
Melhem M Solh, Asad Bashey, Scott R Solomon, et al.
Blood Advances
|
March 24, 2023
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors
Asad Bashey, Xu Zhang, Lawrence E Morris, et al.
Blood Advances
|
September 24, 2025
Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation
Bhavna Bhasin-Chhabra, Tao Wang, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 3, 2017
Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint
Melhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2017
Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant
Scott R Solomon, Connie Sizemore, Xu Zhang, et al.
Page
of 13